MOESM1 of Stapled EGFR peptide reduces inflammatory breast cancer and inhibits additional HER-driven models of cancer

Maisel, Sabrina; Broka, Derrick; Atwell, Benjamin; Bunch, Thomas; Kupp, Robert; Singh, Shiv; Mehta, Shwetal; Schroeder, Joyce

doi:10.6084/m9.figshare.8294573.v1

12967_2019_1939_MOESM1_ESM.docx (554.6 kB)

MOESM1 of Stapled EGFR peptide reduces inflammatory breast cancer and inhibits additional HER-driven models of cancer

journal contribution

posted on 2019-06-18, 05:00 authored by Sabrina Maisel, Derrick Broka, Benjamin Atwell, Thomas Bunch, Robert Kupp, Shiv Singh, Shwetal Mehta, Joyce Schroeder

Additional file 1. Additional data for novel pan-HER therapeutic. Figure S1. Cell line HER protein expression. Figure S2. IV-SAH5-EJ1 post 24Â h. Figure S3. Glioma-luciferase in vivo. Table S1. Peptide COA. Table S2. Injection site reactogenicity. Table S3. Toxicity main study. Table S4. Treatment observation. Table S5. Absolute organ weight.